E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Novartis
Brigham and Women's Hospital
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
Universitair Ziekenhuis Brussel
Incyte Corporation
Weill Medical College of Cornell University
LigaChem Biosciences, Inc.
Merck Sharp & Dohme LLC
Institut Claudius Regaud
Sahlgrenska University Hospital
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Instituto do Cancer do Estado de São Paulo
Sunnybrook Health Sciences Centre
UNICANCER
Assistance Publique - Hôpitaux de Paris
Sotio Biotech Inc.
University of Maryland, College Park
The Affiliated Hospital of Qingdao University
AIDS Malignancy Consortium
University Hospital, Toulouse
SCG Cell Therapy Pte. Ltd.
Corregene Biotechnology Co., Ltd
University of Maryland, College Park
HRYZ Biotech Co.
Dana-Farber Cancer Institute
Charite University, Berlin, Germany
M.D. Anderson Cancer Center
Inovio Pharmaceuticals
Xencor, Inc.
National Institutes of Health Clinical Center (CC)
Beijing Health Guard Biotechnology, Inc
Beijing Health Guard Biotechnology, Inc
Institut de Cancérologie de Lorraine
Beijing Health Guard Biotechnology, Inc
Rubius Therapeutics
Xencor, Inc.
Corregene Biotechnology Co., Ltd
University Health Network, Toronto
Institut de Cancérologie de Lorraine
Karolinska Institutet
AIDS Malignancy Consortium
Abramson Cancer Center at Penn Medicine
Boston Medical Center
Antiva Biosciences
University of Iowa